GRIT BIOTECHNOLOGY
Live / Applied — Opposition pending (as of 07 Nov 2023)
What this means for you
Not registered yet, but its 07 Jul 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97492265
- Mark type
- Stylized text
- Filed
- 07 Jul 2022
- Published for opposition
- 11 Jul 2023
- Attorney of record
- KENNETH A. KNOX
Goods and services
- Class 005 — Pharmaceuticals: Anti-cancer preparations, namely, biological preparations for developing T-cell based immunotherapy by building a series of proprietary tumor infiltrating lymphocyte; Anti-cancer preparations, namely, medical cell function activating drugs for developing T-cell based immunotherapy by building a series of proprietary tumor infiltrating lymphocyte; anti-cancer preparations in the nature of biological agents for treating cancer, namely, for treatment of solid tumor cancers by tumor infiltrating lymphocyte (TIL) therapy; Tumor suppressing agents for treating cancer, namely, for treatment of solid tumor cancers by TIL therapy
Owner
- Suzhou GRIT BIOTECHNOLOGY Co., Ltd., Suzhou, CN
- Suzhou GRIT BIOTECHNOLOGY Co., Ltd., Suzhou, CN
Prosecution history
- 13 May 2024 — ASSIGNED TO EXAMINER
- 07 Nov 2023 — OPPOSITION INSTITUTED NO. 999999
- 04 Aug 2023 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 11 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Jul 2023 — PUBLISHED FOR OPPOSITION
- 21 Jun 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Jun 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 May 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 May 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 May 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Apr 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Apr 2023 — NON-FINAL ACTION E-MAILED
- 27 Apr 2023 — NON-FINAL ACTION WRITTEN
- 21 Apr 2023 — ASSIGNED TO EXAMINER
- 12 Jul 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED